SCHEMBL18740487

SCHEMBL18740487

CCCN(CCC)C(=O)c1cc(Br)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.50
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
GFER P55789 1/20 0.47
HSD17B10 Q99714 1/20 0.47
APP P05067 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 3/20 0.45
NPSR1 Q6W5P4 3/20 0.45
STAT3 P40763 1/20 0.44
ACHE P22303 1/20 0.44
HTR4 Q13639 1/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.43
KDM4E B2RXH2 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21177436 0.85 USP2 (0.45) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL30514825 0.85 USP2 (0.45) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL18767226 0.81 CA12 (0.53) TP53ALDH1A1CYP1A2APPPOLB
SCHEMBL18767227 0.80 KDM4E (0.54) TP53ALDH1A1SMN1; SMN2MAPTCYP1A2
SCHEMBL21189712 0.80 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL21177597 0.78 POLB (0.48) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL6270450 0.77 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL20855483 0.76 HMGCR (0.53) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL21179414 0.76 MAPT (0.46) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9
SCHEMBL30362007 0.76 POLB (0.63) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066742-A1 BACE-2 INHIBITORY COMPOUNDS AND RELATED METHODS OF USE JORTAN PHARMACEUTICALS INC. (US) 2017-04-20 WO disclosed
WO-2017066742-A1 BACE-2 INHIBITORY COMPOUNDS AND RELATED METHODS OF USE JORTAN PHARMACEUTICALS INC. (US) 2017-04-20 WO disclosed